Immunovia AB (publ) total revenue, net income and dynamics of changes in Swedish krona today
Immunovia AB (publ) current income and income for the latest reporting periods. The dynamics of Immunovia AB (publ) net revenue decreased by -29 000 kr from the last reporting period. These are the main financial indicators of Immunovia AB (publ). Immunovia AB (publ) online financial report chart. Immunovia AB (publ) financial report on a graph in real time displays the dynamics, i.e. change in fixed assets of the company. The value of "net income" Immunovia AB (publ) on the graph is displayed in blue.
Report date
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
and
Change (%)
Comparing current quartal report this year to quartal report last year.
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
and
Change (%)
Comparing current quartal report this year to quartal report last year.
31/03/2021
123 000 kr
-97.953 % ↓
-23 445 000 kr
-
31/12/2020
152 000 kr
-98.14 % ↓
-46 119 000 kr
-
30/09/2020
37 000 kr
-99.434 % ↓
-38 064 000 kr
-
30/06/2020
159 000 kr
-97.498 % ↓
-34 099 000 kr
-
31/12/2019
8 170 000 kr
-
-32 616 000 kr
-
30/09/2019
6 540 000 kr
-
-25 625 000 kr
-
30/06/2019
6 354 000 kr
-
-29 897 000 kr
-
31/03/2019
6 008 000 kr
-
-26 384 000 kr
-
Show:
to
Immunovia AB (publ) financial report charts
The dates of the latest financial statements of Immunovia AB (publ): 31/03/2019, 31/12/2020, 31/03/2021. Dates and dates of financial statements are established by the laws of the country where the company operates. The current date of the financial report of Immunovia AB (publ) for today is 31/03/2021. Gross profit Immunovia AB (publ) is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services. Gross profit Immunovia AB (publ) is -8 166 000 kr
Immunovia AB (publ) quarterly report dates
Cost of revenue Immunovia AB (publ) is the total cost of producing and distributing of products and services of a company. Cost of revenue Immunovia AB (publ) is 8 289 000 kr Total revenue Immunovia AB (publ) refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods. Total revenue Immunovia AB (publ) is 123 000 kr Operating income Immunovia AB (publ) is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS). Operating income Immunovia AB (publ) is -29 088 000 kr
Net income Immunovia AB (publ) is an entity's income minus cost of goods sold, expenses and taxes for an accounting period. Net income Immunovia AB (publ) is -23 445 000 kr Current assets Immunovia AB (publ) is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year. Current assets Immunovia AB (publ) is 433 172 000 kr Total assets Immunovia AB (publ) refers to the total amount of assets owned by a person or entity. Total assets Immunovia AB (publ) is 635 686 000 kr
31/03/2021
31/12/2020
30/09/2020
30/06/2020
31/12/2019
30/09/2019
30/06/2019
31/03/2019
Gross profit
Gross profit is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services.
-8 166 000 kr
-11 330 000 kr
-12 625 000 kr
-11 595 000 kr
-12 184 000 kr
-13 197 000 kr
-12 891 000 kr
-12 977 000 kr
Cost of revenue
Cost of revenue is the total cost of producing and distributing of products and services of a company.
8 289 000 kr
11 482 000 kr
12 662 000 kr
11 754 000 kr
20 354 000 kr
19 737 000 kr
19 245 000 kr
18 985 000 kr
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
123 000 kr
152 000 kr
37 000 kr
159 000 kr
8 170 000 kr
6 540 000 kr
6 354 000 kr
6 008 000 kr
Operating revenue
Operating revenue is revenue generated from a company's primary business activities. For example, a retailer produces revenue through merchandise sales, and a physician derives revenue from the medical services he/she provides.
-
-
-
-
8 170 000 kr
6 540 000 kr
6 354 000 kr
6 008 000 kr
Operating income
Operating income is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS).
-29 088 000 kr
-38 447 000 kr
-35 432 000 kr
-28 686 000 kr
-29 644 000 kr
-28 044 000 kr
-29 770 000 kr
-27 248 000 kr
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
-23 445 000 kr
-46 119 000 kr
-38 064 000 kr
-34 099 000 kr
-32 616 000 kr
-25 625 000 kr
-29 897 000 kr
-26 384 000 kr
R&D spending
Research and Development spending - cost of investigative activities to improve existing products and procedures or to lead to the development of new products and procedures.
-
-
-
-
-
-
-
-
Operating expense
An operating expense is an expenditure that a business incurs as a result of performing its normal business operations.
29 211 000 kr
38 599 000 kr
35 469 000 kr
28 845 000 kr
37 814 000 kr
34 584 000 kr
36 124 000 kr
33 256 000 kr
Current assets
Current assets is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year.
433 172 000 kr
474 796 000 kr
517 836 000 kr
563 535 000 kr
269 158 000 kr
303 769 000 kr
332 710 000 kr
367 436 000 kr
Total assets
Total assets refers to the total amount of assets owned by a person or entity.
635 686 000 kr
661 178 000 kr
697 089 000 kr
734 551 000 kr
419 366 000 kr
445 342 000 kr
461 577 000 kr
490 758 000 kr
Current cash
Current cash - the sum of all of the cash a company has on the date of report.
425 397 000 kr
468 462 000 kr
510 593 000 kr
556 191 000 kr
263 345 000 kr
297 217 000 kr
327 462 000 kr
359 849 000 kr
Current debt
Current debt is the portion of debt due within a year (12 months) and is listed as a current liability and part of net working capital.
-
-
-
-
28 641 000 kr
22 641 000 kr
27 299 000 kr
25 775 000 kr
Total cash
Total cash - the sum of all of the cash a company has on its books, including petty cash and funds on deposit in a bank.
-
-
-
-
-
-
-
-
Total debt
Total debt is a combination of both short-term and long-term debt. Short-term debts are those that must be paid back within a year. Long-term debt generally includes every liability that must be paid off in more than a year.
-
-
-
-
61 762 000 kr
57 330 000 kr
56 546 000 kr
55 929 000 kr
Debt ratio
Total debt to total assets - is a financial ratio that indicates the percentage of a company's assets that are provided via debt.
-
-
-
-
14.73 %
12.87 %
12.25 %
11.40 %
Shareholders equity
Shareholder's equity (SE) is the owner's claim after subtracting total liabilities from total assets.
571 393 000 kr
599 403 000 kr
633 071 000 kr
668 755 000 kr
357 604 000 kr
388 012 000 kr
405 031 000 kr
434 829 000 kr
Cash flow
Cash flow is the net amount of cash and cash-equivalents being transferred into and out of a business.
-
-
-
-
-22 645 000 kr
-31 196 000 kr
-23 853 000 kr
-14 262 000 kr
Last revenue report of Immunovia AB (publ) was 31/03/2021. According to last financial report total revenue in Immunovia AB (publ) was 123 000 Swedish krona and changed by -97.953% since last year. Net income in Immunovia AB (publ) was -23 445 000 kr in last quartal, net income changes to 0%.
Current cash Immunovia AB (publ) - the sum of all of the cash a company has on the date of report. Current cash Immunovia AB (publ) is 425 397 000 kr
Immunovia AB (publ) stocks data
IMMNOV.ST stock price
Immunovia AB (publ) stock price today, IMMNOV.ST stock quote.
